EGFR and renal pelvis/ureter urothelial carcinoma: EGFR overexpression has been shown to be associated with high tumor grade, metastasis, poor prognosis, metaplastic morphology and secondary bladder recurrence in UTUC [9,10], and tumors with metaplastic features have been shown to react poorly to systemic chemotherapy [29,30].